Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
2025 · Journal of bone oncology · 8 citations
https://doi.org/10.1016/j.jbo.2025.100694